2025 Q4
2025-11-21
Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
View Filing →
2025-11-20
Abbott Laboratories to Acquire Exact Sciences for $105 per share
$105 per share
View Filing →
2025-10-15
Q3 2025 Earnings
Third quarter 2025 results announced
View Filing →
2025 Q3
2025-07-17
Q2 2025 Earnings
Q2 2025 results announced July 17
View Filing →
2025 Q2
2025-05-01
General Counsel Retirement
Hubert L. Allen, EVP General Counsel retiring after transition
View Filing →
2025-04-28
Annual Shareholder Meeting
Board elected, auditors ratified, exec comp approved 89.90%
View Filing →
2025-04-16
Q1 2025 Earnings
Q1 2025 results announced
View Filing →
2025 Q1
2025-01-22
Q4 2024 Earnings
Q4 and full year 2024 results announced
View Filing →
2024 Q4
2024-11-15
Change in Control Agreements Extended
Executive agreements extended through Dec 31, 2026
View Filing →
2024-10-16
Q3 2024 Earnings
Third quarter 2024 results announced Oct 16, 2024
View Filing →
2024 Q3
2024-07-18
Q2 2024 Earnings
Q2 2024 results announced
View Filing →
2024 Q2
2024-05-01
CFO Retirement
Robert E. Funck, Jr. retiring July 1, 2024 after 36 years
View Filing →
2024-04-29
Annual Shareholder Meeting
Board re-elected, auditor ratified, exec comp approved 89.10%
View Filing →
2024-04-17
Q1 2024 Earnings
First quarter 2024 results announced
View Filing →
2024 Q1
2024-01-29
Credit Agreement Renewal
$5B revolving credit facility, 5-year term
View Filing →
2024-01-24
Q4 2023 Earnings
Q4 and full year 2023 results announced
View Filing →
2023 Q4
2023-10-18
Q3 2023 Earnings
Results announced for third quarter 2023
View Filing →
2023 Q3
2023-07-20
Q2 2023 Earnings
Q2 2023 results announced July 20
View Filing →